We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: ‘Lite’ Confidentiality Pacts Could Reduce Industry Burden
EMA: ‘Lite’ Confidentiality Pacts Could Reduce Industry Burden
April 15, 2010
A new type of confidentiality agreement under construction by the European Medicines Agency (EMA) could reduce the regulatory burden on drugmakers seeking
to market products internationally.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor